Skip to main content

Advertisement

Log in

Tramadol Use in Perioperative Care and Current Controversies

  • Acute Pain Medicine (R Urman, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The aim of this review is to discuss the use of tramadol in the perioperative period. There is no doubt that tramadol has revolutionized pain treatment, making it important to understand the pharmacokinetics and pharmacodynamics in order to provide patients with the safest and most effective analgesia.

Recent Findings

Tramadol is a centrally acting synthetic analgesic with a multimode of action used to help treat moderate to severe pain. Pharmacologically, the unique opioid acts as a serotonin-norepinephrine reuptake inhibitor, while its metabolite, O-desmethyltramadol, acts on the μ-opioid receptor. The analgesic strength of tramadol is about one-tenth that of morphine, making it a relatively safe analgesic. Potential side effects of tramadol include nausea, vomiting, constipation, pruritus, and respiratory depression; however, the severity of these symptoms is minimal compared to traditional opioids.

Summary

Although some of the perioperative uses of tramadol may be rare, it is a pain management option to consider when alternatives have proved ineffective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–82. https://doi.org/10.1097/j.pain.0000000000001939.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–6. https://doi.org/10.1097/j.pain.0000000000000507.

    Article  PubMed  Google Scholar 

  3. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2004;100(6):1573–81. https://doi.org/10.1097/00000542-200406000-00033.

    Article  Google Scholar 

  4. Gregory TB, Settles K. Perioperative pain plan: why is it needed. Pract Pain Manag. 2013;13(9):41–6.

    Google Scholar 

  5. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. https://doi.org/10.2165/00003088-200443130-00004.

    Article  CAS  PubMed  Google Scholar 

  6. •• Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg. 2017;124(1):44–51. https://doi.org/10.1213/ANE.0000000000001683. This study discussed drug-drug interactions between tramadol and many other medications in detail.

  7. Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–45. https://doi.org/10.1001/jama.2016.1464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Aporado CB, Tantri L, Tanchoco L. The analgesic efficacy of tramadol as a pre-emptive analgesic in pediatric appendectomy patients. MOJ Surg. 2015;2(3):63–8. https://doi.org/10.15406/mojs.2015.02.00021

  9. Wang J, Li H, Ma H, Wang N. Effect of preemptive flurbiprofen axetil and tramadol on transurethral resection of the prostate under spinal anesthesia. Pain Res Treat. 2016;2016:3942040. https://doi.org/10.1155/2016/3942040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Reines SA, Goldmann B, Harnett M, Lu L. Misuse of tramadol in the United States: an analysis of the National Survey of Drug Use and Health 2002–2017. Subst Abuse. 2020;14:1178221820930006. https://doi.org/10.1177/1178221820930006.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Issac Z, Atlas S, Kunis L. Management of non-radicular neck pain in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate. 2021. Accessed 27 Dec 2019.

  12. Pino CA, Wakeman SA. Prescription of opioids for acute pain in opioid naïve patients. Post TW, ed. UpToDate. Waltham, MA: UpToDate. 2021. Accessed 8 Jan 2021.

  13. Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18(4):395–400.

    PubMed  Google Scholar 

  14. Zeng C, Dubreuil M, LaRochelle MR, et al. Association of tramadol with all-cause mortality among patients with osteoarthritis. JAMA. 2019;321(10):969–82. https://doi.org/10.1001/jama.2019.1347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. US FDA. ULTRAM® C IV (tramadol hydrochloride) Tablets. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020281s039lbl.pdf. Accessed 16 Oct 2021.

  16. Bravo L, Mico JA, Berrocoso E. Discovery and development of tramadol for the treatment of pain. Expert Opin Drug Discov. 2017;12(12):1281–91. https://doi.org/10.1080/17460441.2017.1377697.

    Article  CAS  PubMed  Google Scholar 

  17. Lassen D, Damkier P, Brøsen K. The pharmacogenetics of tramadol. Clin Pharmacokinet. 2015;54(8):825–36. https://doi.org/10.1007/s40262-015-0268-0.

    Article  CAS  PubMed  Google Scholar 

  18. Dean L, Kane M. Tramadol therapy and CYP2D6 genotype. In: Pratt VM, Scott SA, Pirmohamed M, et al., eds. Medical genetics summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2015.

  19. • Wen QH, Zhang Z, Cai WK, Lin XQ, He GH. The associations between CYP2D6* 10 C188T polymorphism and pharmacokinetics and clinical outcomes of tramadol: a systematic review and meta-analysis. Pain Med. 2020;21(12):3679–90. https://doi.org/10.1093/pm/pnaa140. This meta-analysis provides comprehensive data showing CYP2D6*10 C188T polymorphism had a significant influence on tramadol pharmacokinetics and analgesic effect, but not postoperative nausea and vomiting.

  20. Dean L, Kane M. Aripiprazole therapy and CYP2D6 genotype. In: Pratt VM, Scott SA, Pirmohamed M, et al., eds. Medical genetics summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2016.

  21. Lopes GS, Bielinski SJ, Moyer AM, et al. Sex differences in associations between CYP2D6 phenotypes and response to opioid analgesics. Pharmacogenomics Pers Med. 2020;13:71–9. https://doi.org/10.2147/PGPM.S239222.

    Article  CAS  Google Scholar 

  22. Heise CW, Gallo T, Curry SC, Woosley RL. Identification of populations likely to benefit from pharmacogenomic testing. Pharmacogenet Genomics. 2020;30(5):91–5. https://doi.org/10.1097/FPC.0000000000000400.

    Article  CAS  PubMed  Google Scholar 

  23. Mayo Clinic. Tramadol (oral route) side effects. 2021. https://www.mayoclinic.org/drugs-supplements/tramadol-oral-route/side-effects/drg-20068050?p=1. Accessed 16 Oct 2021.

  24. Tsaousi GG, Chatzistravou A, Papazisis G, Grosomanidis V, Kouvelas D, Pourzitaki C. Analgesic efficacy and safety of local infiltration of tramadol in pediatric tonsillectomy pain: a systematic review and meta-analysis. Pain Pract. 2020;20(5):550–63. https://doi.org/10.1111/papr.12874.

    Article  PubMed  Google Scholar 

  25. Takeshita J, Litzinger MH. Serotonin syndrome associated with tramadol. Prim Care Companion J Clin Psychiatry. 2009;11(5):273. https://doi.org/10.4088/PCC.08l00690.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60(1):139–76. https://doi.org/10.2165/00003495-200060010-00008.

    Article  CAS  PubMed  Google Scholar 

  27. Trekova N, Bunatian A, Zolicheva N. Tramadol hydrochloride in the management of postoperative shivering: a double-blind trial with placebo [abstract 264]. In: 9th World Congress on Pain, Vienna; 1999. pp. 22–7.

  28. Wang N, Wang R, Chen Y, Zhang W, Wang J. Pethidine versus tramadol for shivering treatment after spinal anaesthesia: a meta-analysis of randomized controlled trials. Indian J Surg. 2020:1–6. https://doi.org/10.1007/s12262-020-02615-y.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandra Victor.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Acute Pain Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogbemudia, B., Qu, G., Henson, C. et al. Tramadol Use in Perioperative Care and Current Controversies. Curr Pain Headache Rep 26, 241–246 (2022). https://doi.org/10.1007/s11916-022-01021-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-022-01021-1

Keywords

Navigation